Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma
Simon P. Kim, Paul L. Crispen, R. Houston Thompson, Christopher J. Weight, Stephen A. Boorjian, Brian A. Costello, Christine M. Lohse, Bradley C. LeibovichТом:
118
Рік:
2012
Мова:
english
Сторінки:
1
DOI:
10.1002/cncr.26695
Файл:
PDF, 286 KB
english, 2012